A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Recruiting now · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Healthy Volunteers, Pulmonary Arterial Hypertension
In brief
A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
Key facts
- Study ID
- NCT06649110
- Run by
- Novartis Pharmaceuticals
- People needed
- 232
- Starts
- 2024-10-24
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-07-21
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.
Where it is running
- UC Irvine Medical Center — Orange, California, United States (enrolling)
- Stanford Medical Center — Stanford, California, United States (enrolling)
- Univ Colorado Hospital — Aurora, Colorado, United States (enrolling)
- Central Florida Pulmonary Group — Orlando, Florida, United States (enrolling)
- University of South Florida — Tampa, Florida, United States (enrolling)
- Emory University School of Medicine — Atlanta, Georgia, United States (enrolling)
- U of Kansas Medical Center — Kansas City, Kansas, United States (enrolling)
- Norton Infectious Diseases Specialists — Louisville, Kentucky, United States (enrolling)
- Tufts Medical Center — Boston, Massachusetts, United States (enrolling)
- Lahey Hospital and Medical Center — Burlington, Massachusetts, United States (enrolling)
- Sky Integrative Medical Center SKYCRNG PPDS — Ridgeland, Mississippi, United States (enrolling)
- Summit Health Eastside Clinic — Bend, Oregon, United States (enrolling)
- Allegheny General Hospital — Pittsburgh, Pennsylvania, United States (enrolling)
- Statcare Pulmonary Consultants — Knoxville, Tennessee, United States (enrolling)
- PPD Development LP — Austin, Texas, United States (enrolling)
- PPD Development LP — Austin, Texas, United States (enrolling)
- UT Southwestern Medical Center — Dallas, Texas, United States (enrolling)
- The University of Utah — Salt Lake City, Utah, United States (enrolling)
- Pul Ass Richmond Inc P A R — Richmond, Virginia, United States (enrolling)
- Novartis Investigative Site — Buenos Aires, Buenos Aires F.D., Argentina (enrolling)
- Novartis Investigative Site — CABA, Argentina (enrolling)
- Novartis Investigative Site — Río Cuarto, Argentina (enrolling)
- Novartis Investigative Site — San Miguel de Tucumán, Argentina (enrolling)
- Novartis Investigative Site — Santa Fe, Argentina (enrolling)
- Arizona Pulmonary Specialists Ltd — Scottsdale, Arizona, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.